Taking the advantage of similar genomic characteristics of tumor nodules in multifocal HCC patients, Huang et al. revealed that small tumors had higher immune cell infiltration and better sensitivity to anti-PD-1 therapy compared with large tumors (82). Here, PDCD1 is linked to neoplasm.